AbbVie will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. The company's management will engage in a fireside chat at 9:40 a.m. Central time, which will be webcast live on AbbVie's Investor Relations website. This event provides investors and the public an opportunity to hear directly from AbbVie's leadership about their strategies and developments in key therapeutic areas such as immunology, neuroscience, and oncology. An archived version of the session will be available later the same day for those who cannot attend live.
SkinMedica, part of Allergan Aesthetics under AbbVie, has launched a Regenerative Science Advisory Board composed of leading skin health experts to guide future innovation. The company also expanded its R&D facility in Irvine, California, integrating...
Big pharmaceutical companies are confronting a $300 billion loss in drug patents by 2030, prompting a surge in acquisitions of mid-size biotech firms with promising drug pipelines. In 2026, biopharma deal values are expected to exceed $250 billion, t...
